Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;32(3):302-308.
doi: 10.1038/s41431-023-01504-8. Epub 2023 Dec 7.

Psychological impact of additional findings detected by genome-wide Non-Invasive Prenatal Testing (NIPT): TRIDENT-2 study

Affiliations

Psychological impact of additional findings detected by genome-wide Non-Invasive Prenatal Testing (NIPT): TRIDENT-2 study

Iris M Bakkeren et al. Eur J Hum Genet. 2024 Mar.

Abstract

In the Netherlands, genome-wide non-invasive prenatal testing (NIPT) is offered to all pregnant women as part of the nationwide TRIDENT-2 study. Findings other than trisomy 21, 18, or 13, which are called "additional findings", are reported only on request of the pregnant woman. This study examined: (1) women's pre-test perceptions and reasons to opt for additional findings and (2) women's experiences with- and the psychological impact of being informed about an additional finding. A questionnaire, consisting of the anxiety measure State-Trait Anxiety Inventory (STAI), distress measure Impact of Event Scale (IES) and questions developed specifically for this study, was retrospectively administered to 402 women who received an additional finding. A total of 227 (56.5%) women completed the questionnaire. Most (60.2%) chose to know additional findings because they wanted as much information as possible about the health of their fetus. Almost all (92%) stated that receiving the additional finding was unexpected, a shock, and/or they were in disbelief, for 85% it caused a lot of worry. Post-test, high anxiety (STAI) levels were reported in 15.5% of women, and 7.5% reported severe distress (IES). Women who gave birth to an affected child (n = 10) experienced most psychological impact (STAI and IES). Eighty-six percent of women with a fetal aberration would opt for additional findings again, compared to 49.2% of women whose result was confined to the placenta. Pre-test counseling should focus on explaining the different results NIPT can generate. Post-test counseling should focus on guiding pregnant women through this uncertain and anxious time.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Overview of the different NIPT results after confirmation by follow-up testing or confirmation after birth.
MC Miscarriage, MM maternal malignancy, RAT Rare Autosomal Trisomy, SA Structural chromosomal aberration, TOP termination of pregnancy, VT vanishing twin. *Unknown whether chromosomal abnormality detected by NIPT was a Rare Autosomal Trisomy (RAT) or Structural chromosomal aberration.

References

    1. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–7. doi: 10.1016/S0140-6736(97)02174-0. - DOI - PubMed
    1. Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn. 2015;35:972–9. doi: 10.1002/pd.4601. - DOI - PubMed
    1. Ravitsky V, Roy M-C, Haidar H, Henneman L, Marshall J, Newson AJ, et al. The Emergence and Global Spread of Noninvasive Prenatal Testing. Annu Rev Genom. Hum Genet. 2021;22:309–38. doi: 10.1146/annurev-genom-083118-015053. - DOI - PubMed
    1. van Opstal D, Van Maarle MC, Lichtenbelt K, Weiss MM, Schuring-Blom H, Bhola SL, et al. Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study. Genet Med. 2018;20:480–5. doi: 10.1038/gim.2017.132. - DOI - PMC - PubMed
    1. Fiorentino F, Bono S, Pizzuti F, Duca S, Polverari A, Faieta M, et al. The clinical utility of genome‐wide non invasive prenatal screening. Prenat Diagn. 2017;37:593–601. doi: 10.1002/pd.5053. - DOI - PubMed

LinkOut - more resources